학술논문

Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals
Document Type
article
Author
Collaborative, Epi25Feng, Yen-Chen AnneHowrigan, Daniel PAbbott, Liam ETashman, KatherineCerrato, FeleciaSingh, TarjinderHeyne, HenrikeByrnes, AndreaChurchhouse, ClaireWatts, NickSolomonson, MatthewLal, DennisHeinzen, Erin LDhindsa, Ryan SStanley, Kate ECavalleri, Gianpiero LHakonarson, HakonHelbig, IngoKrause, RolandMay, PatrickWeckhuysen, SarahPetrovski, SlavéKamalakaran, SitharthanSisodiya, Sanjay MCossette, PatrickCotsapas, ChrisDe Jonghe, PeterDixon-Salazar, TracyGuerrini, RenzoKwan, PatrickMarson, Anthony GStewart, RandyDepondt, ChantalDlugos, Dennis JScheffer, Ingrid EStriano, PasqualeFreyer, CatharineMcKenna, KevinRegan, Brigid MBellows, Susannah TLeu, CostinBennett, Caitlin AJohns, Esther MCMacdonald, AlexandraShilling, HannahBurgess, RosemaryWeckhuysen, DorienBahlo, MelanieO’Brien, Terence JTodaro, MarianStamberger, HannahAndrade, Danielle MSadoway, Tara RMo, KellyKrestel, HeinzGallati, SabinaPapacostas, Savvas SKousiappa, IoannaTanteles, George AŠtěrbová, KatalinVlčková, MarkétaSedláčková, LucieLaššuthová, PetraKlein, Karl MartinRosenow, FelixReif, Philipp SKnake, SusanneKunz, Wolfram SZsurka, GáborElger, Christian EBauer, JürgenRademacher, MichaelPendziwiat, ManuelaMuhle, HiltrudRademacher, Annikavan Baalen, Andreasvon Spiczak, SarahStephani, UlrichAfawi, ZaidKorczyn, Amos DKanaan, MoienCanavati, ChristinaKurlemann, GerhardMüller-Schlüter, KarenKluger, GerhardHäusler, MartinBlatt, IlanLemke, Johannes RKrey, IlonaWeber, Yvonne GWolking, StefanBecker, FelicitasHengsbach, ChristianRau, SarahMaisch, Ana FSteinhoff, Bernhard JSchulze-Bonhage, AndreasSchubert-Bast, SusanneSchreiber, Herbert
Source
American Journal of Human Genetics. 105(2)
Subject
Clinical Research
Human Genome
Neurosciences
Epilepsy
Biotechnology
Genetics
Neurodegenerative
Brain Disorders
2.1 Biological and endogenous factors
Aetiology
Neurological
Case-Control Studies
DNA Mutational Analysis
Exome
Genetic Markers
Genetic Predisposition to Disease
Genetic Variation
Humans
Phenotype
Exome Sequencing
Epi25 Collaborative. Electronic address: s.berkovic@unimelb.edu.au
Epi25 Collaborative
burden analysis
epilepsy
epileptic encephalopathy
exome
seizures
sequencing
Biological Sciences
Medical and Health Sciences
Genetics & Heredity
Language
Abstract
Sequencing-based studies have identified novel risk genes associated with severe epilepsies and revealed an excess of rare deleterious variation in less-severe forms of epilepsy. To identify the shared and distinct ultra-rare genetic risk factors for different types of epilepsies, we performed a whole-exome sequencing (WES) analysis of 9,170 epilepsy-affected individuals and 8,436 controls of European ancestry. We focused on three phenotypic groups: severe developmental and epileptic encephalopathies (DEEs), genetic generalized epilepsy (GGE), and non-acquired focal epilepsy (NAFE). We observed that compared to controls, individuals with any type of epilepsy carried an excess of ultra-rare, deleterious variants in constrained genes and in genes previously associated with epilepsy; we saw the strongest enrichment in individuals with DEEs and the least strong in individuals with NAFE. Moreover, we found that inhibitory GABAA receptor genes were enriched for missense variants across all three classes of epilepsy, whereas no enrichment was seen in excitatory receptor genes. The larger gene groups for the GABAergic pathway or cation channels also showed a significant mutational burden in DEEs and GGE. Although no single gene surpassed exome-wide significance among individuals with GGE or NAFE, highly constrained genes and genes encoding ion channels were among the lead associations; such genes included CACNA1G, EEF1A2, and GABRG2 for GGE and LGI1, TRIM3, and GABRG2 for NAFE. Our study, the largest epilepsy WES study to date, confirms a convergence in the genetics of severe and less-severe epilepsies associated with ultra-rare coding variation, and it highlights a ubiquitous role for GABAergic inhibition in epilepsy etiology.